Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

NEO – Neogenomics Inc.

Float Short %

8.12

Margin Of Safety %

Put/Call OI Ratio

0.23

EPS Next Q Diff

0.09

EPS Last/This Y

EPS This/Next Y

0.16

Price

9.88

Target Price

13.83

Analyst Recom

2.29

Performance Q

-5

Upside

-397.3%

Beta

1.61

Ticker: NEO




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-01-23NEO12.810.200.0517410
2026-01-26NEO12.430.200.0017421
2026-01-27NEO12.480.200.3317446
2026-01-28NEO12.380.20999.9917449
2026-01-29NEO12.420.209.3117444
2026-01-30NEO12.060.200.0017495
2026-02-02NEO12.310.211.6517105
2026-02-03NEO12.510.210.0917069
2026-02-04NEO11.980.210.0117082
2026-02-05NEO11.260.210.0017065
2026-02-06NEO11.410.210.0016621
2026-02-09NEO11.310.220.7116419
2026-02-10NEO11.510.220.1316428
2026-02-11NEO11.440.220.0216430
2026-02-12NEO11.170.220.2816437
2026-02-13NEO11.380.220.9216504
2026-02-17NEO11.430.220.9216544
2026-02-18NEO10.230.240.2216810
2026-02-19NEO100.240.0316797
2026-02-20NEO9.880.230.2416780
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-01-23NEO12.810.0- 0.10
2026-01-26NEO12.420.0- 0.10
2026-01-27NEO12.450.0- 0.10
2026-01-28NEO12.36-2.3- 0.10
2026-01-29NEO12.42-2.3- 0.10
2026-01-30NEO12.07-2.3- 0.10
2026-02-02NEO12.32-2.3- 0.10
2026-02-03NEO12.51-2.3- 0.10
2026-02-04NEO11.98-2.3- 0.10
2026-02-05NEO11.26-2.3- 0.10
2026-02-06NEO11.41-2.3- 0.10
2026-02-09NEO11.34-2.3- 0.10
2026-02-10NEO11.51-2.3- 0.10
2026-02-11NEO11.44-2.3- 0.10
2026-02-12NEO11.19-2.3- 0.10
2026-02-13NEO11.31-2.3- 0.10
2026-02-17NEO11.44-2.3- 0.10
2026-02-18NEO10.230.0- 0.10
2026-02-19NEO10.000.0- 0.10
2026-02-20NEO9.880.0- 0.16
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-01-23NEO-0.08-1.416.40
2026-01-26NEO-0.08-0.936.39
2026-01-27NEO-0.08-0.936.39
2026-01-28NEO-0.08-0.936.57
2026-01-29NEO-0.08-0.936.57
2026-01-30NEO-0.08-0.936.57
2026-02-02NEO-0.08-1.026.57
2026-02-03NEO-0.08-1.026.57
2026-02-04NEO-0.08-1.026.57
2026-02-05NEO-0.08-1.026.57
2026-02-06NEO-0.08-1.026.57
2026-02-09NEO-0.683.566.57
2026-02-10NEO-0.683.566.57
2026-02-11NEO-0.683.568.14
2026-02-12NEO-0.683.568.14
2026-02-13NEO-0.683.568.14
2026-02-17NEO-0.687.018.14
2026-02-18NEO-0.687.018.14
2026-02-19NEO-0.687.018.14
2026-02-20NEO-0.677.018.12
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.05

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

0.04

Insider Transactions

-0.67

Institutional Transactions

7.01

Beta

1.61

Average Sales Estimate Current Quarter

184

Average Sales Estimate Next Quarter

196

Fair Value

Quality Score

41

Growth Score

43

Sentiment Score

33

Actual DrawDown %

82.4

Max Drawdown 5-Year %

-91.4

Target Price

13.83

P/E

Forward P/E

31.72

PEG

0.59

P/S

1.77

P/B

1.52

P/Free Cash Flow

EPS

-0.84

Average EPS Est. Cur. Y​

0.16

EPS Next Y. (Est.)

0.32

Target Price Estimates Raised

1

Target Price Estimates Lowered

Profit Margin

-14.85

Relative Volume

0.98

Return on Equity vs Sector %

-42.5

Return on Equity vs Industry %

-24.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

NeoGenomics, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 2500
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
stock quote shares NEO – Neogenomics Inc. Stock Price stock today
news today NEO – Neogenomics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NEO – Neogenomics Inc. yahoo finance google finance
stock history NEO – Neogenomics Inc. invest stock market
stock prices NEO premarket after hours
ticker NEO fair value insiders trading

NEO – NeoGenomics, Inc.

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=NEO #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=NEO &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

8.12

Margin Of Safety %

Put/Call OI Ratio

0.23

EPS Next Q Diff

0.09

EPS Last/This Y

EPS This/Next Y

0.16

Price

9.88

Target Price

13.83

Analyst Recom

2.29

Performance Q

-5

Upside

-397.3%

Beta

1.61

Ticker: NEO




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-01-23NEO12.810.200.0517410
2026-01-26NEO12.430.200.0017421
2026-01-27NEO12.480.200.3317446
2026-01-28NEO12.380.20999.9917449
2026-01-29NEO12.420.209.3117444
2026-01-30NEO12.060.200.0017495
2026-02-02NEO12.310.211.6517105
2026-02-03NEO12.510.210.0917069
2026-02-04NEO11.980.210.0117082
2026-02-05NEO11.260.210.0017065
2026-02-06NEO11.410.210.0016621
2026-02-09NEO11.310.220.7116419
2026-02-10NEO11.510.220.1316428
2026-02-11NEO11.440.220.0216430
2026-02-12NEO11.170.220.2816437
2026-02-13NEO11.380.220.9216504
2026-02-17NEO11.430.220.9216544
2026-02-18NEO10.230.240.2216810
2026-02-19NEO100.240.0316797
2026-02-20NEO9.880.230.2416780
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-01-23NEO12.810.0- 0.10
2026-01-26NEO12.420.0- 0.10
2026-01-27NEO12.450.0- 0.10
2026-01-28NEO12.36-2.3- 0.10
2026-01-29NEO12.42-2.3- 0.10
2026-01-30NEO12.07-2.3- 0.10
2026-02-02NEO12.32-2.3- 0.10
2026-02-03NEO12.51-2.3- 0.10
2026-02-04NEO11.98-2.3- 0.10
2026-02-05NEO11.26-2.3- 0.10
2026-02-06NEO11.41-2.3- 0.10
2026-02-09NEO11.34-2.3- 0.10
2026-02-10NEO11.51-2.3- 0.10
2026-02-11NEO11.44-2.3- 0.10
2026-02-12NEO11.19-2.3- 0.10
2026-02-13NEO11.31-2.3- 0.10
2026-02-17NEO11.44-2.3- 0.10
2026-02-18NEO10.230.0- 0.10
2026-02-19NEO10.000.0- 0.10
2026-02-20NEO9.880.0- 0.16
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-01-23NEO-0.08-1.416.40
2026-01-26NEO-0.08-0.936.39
2026-01-27NEO-0.08-0.936.39
2026-01-28NEO-0.08-0.936.57
2026-01-29NEO-0.08-0.936.57
2026-01-30NEO-0.08-0.936.57
2026-02-02NEO-0.08-1.026.57
2026-02-03NEO-0.08-1.026.57
2026-02-04NEO-0.08-1.026.57
2026-02-05NEO-0.08-1.026.57
2026-02-06NEO-0.08-1.026.57
2026-02-09NEO-0.683.566.57
2026-02-10NEO-0.683.566.57
2026-02-11NEO-0.683.568.14
2026-02-12NEO-0.683.568.14
2026-02-13NEO-0.683.568.14
2026-02-17NEO-0.687.018.14
2026-02-18NEO-0.687.018.14
2026-02-19NEO-0.687.018.14
2026-02-20NEO-0.677.018.12
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=NEO 589 360 ]

Last Quarter Act. EPS

-0.05

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

0.04

Insider Transactions

-0.67

Institutional Transactions

7.01

Beta

1.61

Average Sales Estimate Current Quarter

184

Average Sales Estimate Next Quarter

196

Fair Value

Quality Score

41

Growth Score

43

Sentiment Score

33

Actual DrawDown %

82.4

Max Drawdown 5-Year %

-91.4

Target Price

13.83

P/E

Forward P/E

31.72

PEG

0.59

P/S

1.77

P/B

1.52

P/Free Cash Flow

EPS

-0.84

Average EPS Est. Cur. Y​

0.16

EPS Next Y. (Est.)

0.32

Target Price Estimates Raised

1

Target Price Estimates Lowered

Profit Margin

-14.85

Relative Volume

0.98

Return on Equity vs Sector %

-42.5

Return on Equity vs Industry %

-24.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=NEO 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=NEO 589 450 ]
NeoGenomics, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 2500
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
stock quote shares NEO – NeoGenomics, Inc. Stock Price stock today
news today NEO – NeoGenomics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NEO – NeoGenomics, Inc. yahoo finance google finance
stock history NEO – NeoGenomics, Inc. invest stock market
stock prices NEO premarket after hours
ticker NEO fair value insiders trading